Cargando…
Metalloendopeptidase ADAM-like Decysin 1 (ADAMDEC1) in Colonic Subepithelial PDGFRα(+) Cells Is a New Marker for Inflammatory Bowel Disease
Metalloendopeptidase ADAM-Like Decysin 1 (ADAMDEC1) is an anti-inflammatory peptidase that is almost exclusively expressed in the gastrointestinal (GI) tract. We have recently found abundant and selective expression of Adamdec1 in colonic mucosal PDGFRα(+) cells. However, the cellular origin for thi...
Autores principales: | Ha, Se Eun, Jorgensen, Brian G., Wei, Lai, Jin, Byungchang, Kim, Min-Seob, Poudrier, Sandra M., Singh, Rajan, Bartlett, Allison, Zogg, Hannah, Kim, Sei, Baek, Gain, Kurahashi, Masaaki, Lee, Moon-Young, Kim, Yong-Sung, Choi, Suck-Chei, Sasse, Kent C., Rubin, Samuel J. S., Gottfried-Blackmore, Andres, Becker, Laren, Habtezion, Aida, Sanders, Kenton M., Ro, Seungil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103908/ https://www.ncbi.nlm.nih.gov/pubmed/35563399 http://dx.doi.org/10.3390/ijms23095007 |
Ejemplares similares
-
Transcriptome profiling of subepithelial PDGFRα cells in colonic mucosa reveals several cell-selective markers
por: Ha, Se Eun, et al.
Publicado: (2022) -
Critical Role of the Disintegrin Metalloprotease ADAM-like Decysin-1 [ADAMDEC1] for Intestinal Immunity and Inflammation
por: O’Shea, Nuala R., et al.
Publicado: (2016) -
Elevated ADAM-like Decysin-1 (ADAMDEC1) expression is associated with increased chemo-sensitivity and improved prognosis in breast cancer patients
por: Chai, Na, et al.
Publicado: (2023) -
ADAM-like Decysin-1 (ADAMDEC1) is a positive regulator of Epithelial Defense Against Cancer (EDAC) that promotes apical extrusion of RasV12-transformed cells
por: Yako, Yuta, et al.
Publicado: (2018) -
Smooth Muscle Transcriptome Browser: offering genome-wide references and expression profiles of transcripts expressed in intestinal SMC, ICC, and PDGFRα(+) cells
por: Breland, Adrienne, et al.
Publicado: (2019)